
Background: Programs initiated to prevent iodine deficiency disorders (IDD) may not remain effective due to changes in government policies, commercial factors, and human behavior that may affect the efficacy of IDD prevention programs in unpredictable directions. Monitoring and outcome studies are needed to optimize the effectiveness of IDD prevention. Summary: Although the need for monitoring is compelling, the current reality in Europe is less than optimal. Regular and systematic monitoring surveys have only been established in a few countries, and comparability across the studies is hampered by the lack of centralized standardization procedures. In addition, data on outcomes and the cost of achieving them are needed in order to provide evidence of the beneficial effects of IDD prevention in countries with mild iodine deficiency. Conclusion: Monitoring studies can be optimized by including centralized standardization procedures that improve the comparison between studies. No study of iodine consumption can replace the direct measurement of health outcomes and the evaluation of the costs and benefits of the program. It is particularly important that health economic evaluation should be conducted in mildly iodine-deficient areas and that it should include populations from regions with different environmental, ethnic, and cultural backgrounds.
International Cooperation, DISEASE, Endocrinology & Metabolism, Métabolisme, Hypothyroidism, Outcome Assessment, Health Care, Humans, GENOME-WIDE ASSOCIATION, FORTIFICATION, Diabétologie, Science & Technology, THYROTROPIN, Endocrinology; Endocrinology, Diabetes and Metabolism, Health Care Costs, Thyroid Diseases, Endocrinologie, Diet, Europe, THYROID-FUNCTION, EMC MM-01-39-03, URINARY IODINE, Research Design, DENMARK, GOITER PREVALENCE, Preventive Medicine, FOLLOW-UP, Life Sciences & Biomedicine, IODIZATION, Iodine
International Cooperation, DISEASE, Endocrinology & Metabolism, Métabolisme, Hypothyroidism, Outcome Assessment, Health Care, Humans, GENOME-WIDE ASSOCIATION, FORTIFICATION, Diabétologie, Science & Technology, THYROTROPIN, Endocrinology; Endocrinology, Diabetes and Metabolism, Health Care Costs, Thyroid Diseases, Endocrinologie, Diet, Europe, THYROID-FUNCTION, EMC MM-01-39-03, URINARY IODINE, Research Design, DENMARK, GOITER PREVALENCE, Preventive Medicine, FOLLOW-UP, Life Sciences & Biomedicine, IODIZATION, Iodine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 33 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
